Загрузка...
Drug screening model meets cancer organoid technology
Tumor organoids inherit the genomic and molecular characteristics of the donor tumor, which not only bridge the gap between genome and phenotype but also circumvent the disadvantages such as genetic information change by using 2D cell lines and the mouse-specific tumor evolution in patient-derived x...
Сохранить в:
| Опубликовано в: : | Transl Oncol |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Neoplasia Press
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7451679/ https://ncbi.nlm.nih.gov/pubmed/32822897 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2020.100840 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|